Format

Send to

Choose Destination
J Gen Intern Med. 2018 Dec 12. doi: 10.1007/s11606-018-4779-x. [Epub ahead of print]

Timeliness of Postmarket Studies for New Pharmaceuticals Approved Between 2009 and 2012: a Cross-Sectional Analysis.

Author information

1
Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA. Joshua.wallach@yale.edu.
2
Collaboration for Research Integrity and Transparency, Yale School of Medicine, New Haven, CT, USA. Joshua.wallach@yale.edu.
3
Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT, USA. Joshua.wallach@yale.edu.
4
Collaboration for Research Integrity and Transparency, Yale School of Medicine, New Haven, CT, USA.
5
Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT, USA.
6
Section of General Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
7
Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.
8
National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
9
Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
PMID:
30543020
DOI:
10.1007/s11606-018-4779-x

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center